While Galectin Therapeutics Inc has underperformed by -16.20%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GALT rose by 248.84%, with highs and lows ranging from $6.55 to $0.73, whereas the simple moving average jumped by 116.46% in the last 200 days.
On June 17, 2025, H.C. Wainwright started tracking Galectin Therapeutics Inc (NASDAQ: GALT) recommending Buy. A report published by H.C. Wainwright on August 13, 2020, Reiterated its previous ‘Buy’ rating for GALT. B. Riley FBR also rated GALT shares as ‘Buy’, setting a target price of $11 on the company’s shares in an initiating report dated February 13, 2019. H.C. Wainwright Reiterated the rating as Buy on December 07, 2017, but set its price target from $6 to $10. H.C. Wainwright resumed its ‘Buy’ rating for GALT, as published in its report on November 28, 2017. H.C. Wainwright also rated the stock as ‘Buy’.
Analysis of Galectin Therapeutics Inc (GALT)
To gain a thorough understanding of Galectin Therapeutics Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. Taking into account the quick ratio of the company, currently set at 1.43, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and GALT is recording an average volume of 689.98K. On a monthly basis, the volatility of the stock is set at 9.40%, whereas on a weekly basis, it is put at 17.80%, with a loss of -3.64% over the past seven days. Furthermore, long-term investors anticipate a median target price of $6.00, showing growth from the present price of $4.5, which can serve as yet another indication of whether GALT is worth investing in or should be passed over.
How Do You Analyze Galectin Therapeutics Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 31.41%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 16.44% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
